Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Resources Maintain Upward Trajectory In House Appropriations Committee Bill

This article was originally published in The Pink Sheet Daily

Executive Summary

But advocates worry that new FDA programs being considered on Capitol Hill could drain the revitalization effect of new money.

You may also be interested in...



FDA Appropriations In Senate: Money For Generics; Worry About Tobacco

Senate appropriators would like to see FDA spend $93 million in fiscal year 2010 on its generic drugs program

FDA Appropriations In Senate: Money For Generics; Worry About Tobacco

Senate appropriators would like to see FDA spend $93 million in fiscal year 2010 on its generic drugs program

Commissioner Margaret Hamburg: Moving FDA Beyond A Regulatory Agency

Of the leading candidates for FDA commissioner in the Obama administration, Margaret Hamburg seemed among those with the least relevant experience - an illustrious career to be sure, but one that lacked a decision-making role involving medical products

Related Content

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel